Etrasimod

The AGA has released an updated guideline on pharmacologic management of adult outpatients with UC that, for the ...

FEBRUARY 4, 2025

The AGA has released a new, updated guideline on pharmacologic management of adult outpatients with ulcerative ...

NOVEMBER 26, 2024

Prospective studies that directly compare the efficacy of two different medications remain rare in our field, ...

NOVEMBER 15, 2024

The number of inflammatory bowel disease treatment options with different mechanisms of action has exploded over ...

OCTOBER 13, 2024

The development of effective biologics and small molecule targeted therapies has revolutionized the treatment of ...

SEPTEMBER 5, 2024

In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, discusses five of her favorite abstracts and ...

JULY 12, 2024

New data on a recently approved therapy for ulcerative colitis suggest that its onset of action is uncommonly fast.

JANUARY 29, 2024

In this month’s The Regueiro Report, I’d like to highlight two exciting FDA approvals for moderately to ...

JANUARY 23, 2024

Miguel Regueiro, MD, sat down with us to talk about some of his favorite inflammatory bowel disease research ...

JANUARY 5, 2024

In this installment of “Expert Picks,” Brooks D. Cash, MD, discusses four of his favorite abstracts ...

DECEMBER 26, 2023

The FDA has approved etrasimod (Velsipity, Pfizer), a selective sphingosine-1-phosphate receptor modulator, for ...

OCTOBER 13, 2023

In this installment of “Expert Picks” from DDW 2023, Dana Lukin, MD, PhD, discusses six of his ...

JULY 10, 2023